Online citations, reference lists, and bibliographies.
← Back to Search

Group Cognitive-behavior Therapy For Patients Failing To Respond To Pharmacotherapy For Panic Disorder: A Clinical Case Series.

M. Otto, M. Pollack, S. J. Penava, B. Zucker
Published 1999 · Psychology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The last decade has brought exciting advances to the treatment of panic disorder and agoraphobia, and a variety of cognitive-behavioral and pharmacologic treatment strategies offer clear benefit to patients. Nonetheless, treatment nonresponse continues to be a chronic problem, and additional strategies are needed to aid patients who do not respond fully to initial interventions. In the present study, we use 'services' research to document the clinical response of pharmacotherapy nonresponders to a standard program of brief, group cognitive-behavioral therapy. Patients responded well, regardless of whether they had received a full, adequate trial of pharmacotherapy. In addition to its application as an initial treatment for panic disorder, routine application of cognitive-behavioral therapy in pharmacologic treatment algorithms is encouraged, with attention to referral of pharmacotherapy nonresponders to cognitive-behavioral therapy.
This paper references
ECDEU Assessment Manual for Psychopharmacology
W. Guy (1976)
10.1097/00004714-198103000-00007
Treatment of Panic Disorder
P. Muskin (1981)
10.1016/0005-7967(85)90011-7
Combined pharmacological and behavioral treatment for agoraphobia.
M. Telch (1985)
10.1037/0022-006X.58.1.77
A comparison of alprazolam and behavior therapy in treatment of panic disorder.
J. Klosko (1990)
10.1192/BJP.162.6.776
Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto.
I. Marks (1993)
10.1016/0005-7967(93)90026-Q
Group cognitive-behavioral treatment of panic disorder.
M. Telch (1993)
10.1037/0022-006X.61.2.317
A meta-analysis of treatments for panic disorder.
G. Clum (1993)
Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy.
A. Hoffart (1993)
Cognitive behavior therapy for treatment-refractory panic disorder.
M. Pollack (1994)
10.1192/BJP.164.6.759
A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder.
D. Clark (1994)
Combined pharmacological and psychological treatment of panic disorder: Current status and future directions.
M. Telch (1994)
10.1002/ANXI.3070010402
Course and outcome in panic disorder: a review of recent follow-up studies.
P. Roy-Byrne (1994)
10.1016/S0193-953X(18)30024-8
Cognitive-behavior therapy and the longitudinal course of panic disorder.
M. Otto (1995)
10.1016/0272-7358(95)00048-8
A meta-analysis of treatment outcome for panic disorder
R. Gould (1995)
10.1016/0887-6185(96)00008-4
Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia
D. Sharp (1996)
10.1016/S0005-7894(96)80028-1
Maintenance of remission following cognitive behavior therapy for panic disorder: Possible deleterious effects of concurrent medication treatment
M. Otto (1996)
10.1037/0003-066X.51.10.1050
Health care policy, psychotherapy research, and the future of psychotherapy.
D. Barlow (1996)
10.1177/026988119601000314
The effectiveness of cognitive-behavior therapy for panic disorder without concurrent medication treatment: a reply to Power and Sharp
M. Otto (1996)
10.3928/0048-5713-19960401-09
An Algorithm-Oriented Treatment Approach for Panic Disorder
J. D. Coplan (1996)
10.1111/j.1600-0447.1997.tb09636.x
Overcoming resistance to exposure in panic disorder with agoraphobia
G. Fava (1997)
10.4088/JCP.V58N1208
Determinants of pharmacologic treatment failure in panic disorder.
D. Cowley (1997)
10.1176/AJP.154.11.1571
Multicenter collaborative panic disorder severity scale.
M. Shear (1997)
10.1016/S0005-7967(98)00035-7
Rate of improvement during cognitive-behavioral group treatment for panic disorder.
S. J. Penava (1998)



This paper is referenced by
10.1007/s41811-021-00099-6
The Effects of the Five-Session Cognitive Behavior Group Therapy for Panic Disorders: Ultra-Brief Treatment
Fatih Yığman (2021)
10.1002/da.22895
Aligning the many definitions of treatment resistance in anxiety disorders: A systematic review
Wicher A Bokma (2019)
10.1002/da.22574
Improving outcomes for patients with medication‐resistant anxiety: effects of collaborative care with cognitive behavioral therapy
L. Campbell-Sills (2016)
10.1177/0269881114525674
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology
D. Baldwin (2014)
10.1002/9781118775349.CH46
Panic Disorder: Assessment and Treatment
K. Szuhany (2014)
10.1016/B978-0-12-394427-6.00026-1
A Comparison between Psychosocial and Pharmacological Treatments
M. Powers (2014)
10.1016/j.brat.2013.10.009
Applying the Quadruple Process model to evaluate change in implicit attitudinal responses during therapy for panic disorder.
Elise M. Clerkin (2014)
10.1521/IJCT.2014.7.2.122
Combination Psychological and Pharmacological Treatments for Panic Disorder
K. Szuhany (2014)
10.1007/978-94-017-8669-0_7
The Role of Motivation in Cognitive Behavioural Psychotherapy for Anxiety Disorders
E. Heldt (2014)
A Comparative Study of the Efficacy of Group versus Individual Cognitive Behavior Therapy in the Treatment of Panic Disorder
Farangis Jamali Zadeh (2014)
10.1016/j.jbtep.2012.09.003
Do patterns of change during treatment for panic disorder predict future panic symptoms?
Shari A. Steinman (2013)
Effectiveness of GCBT in Prisoner Population
(2013)
10.1159/000351953
Pharmacological treatment of panic disorder.
B. Bandelow (2013)
10.1080/20786204.2012.10874277
The assessment and treatment of panic disorder in general practice
N. Koen (2012)
10.1177/1073191112436668
Anchoring the Panic Disorder Severity Scale
Meghan E. Keough (2012)
Untitled Page
C. Nemeroff (2012)
10.1002/da.20891
Memory dysfunction in panic disorder: an investigation of the role of chronic benzodiazepine use
T. Deckersbach (2011)
10.1016/j.jad.2010.08.025
CBT for pharmacotherapy non-remitters--a systematic review of a next-step strategy.
H. Rodrigues (2011)
10.1177/1534650110391901
A Time-Series Study of the Treatment of Panic Disorder
Sara R. Elkins (2011)
10.1007/978-1-59745-387-5
Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health
L. Baer (2010)
10.1007/978-1-4419-0612-0_7
Avoiding Treatment Failures in Panic Disorder
Heather W. Murray (2010)
10.1016/j.biopsych.2009.07.036
Efficacy of D-Cycloserine for Enhancing Response to Cognitive-Behavior Therapy for Panic Disorder
M. Otto (2010)
10.1007/978-1-4419-0612-0_5
Combined Cognitive Behavioral and Pharmacologic Treatment Strategies: Current Status and Future Directions
J. Smits (2010)
10.1037/a0021067
Catastrophic misinterpretations as a predictor of symptom change during treatment for panic disorder.
B. Teachman (2010)
10.1111/J.1468-2850.2010.01198.X
Combined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes.
M. Otto (2010)
10.1016/B978-0-12-375096-9.00021-3
Chapter 21 – Comparison between Psychosocial and Pharmacological Treatments
M. Powers (2010)
A Naturalistic Treatment for Panic Disorder The Importance of Emotion-Focused Process
T. Katzenstein (2009)
10.1007/978-1-59745-444-5_3
A Naturalistic Treatment for Panic Disorder
T. Katzenstein (2009)
10.1016/j.psc.2009.05.005
Empirically supported treatments for panic disorder.
R. McHugh (2009)
10.13109/GRUP.2009.45.3.208
Gruppenpsychotherapie der Panikstörung
M. B. Gary (2009)
10.1007/978-1-59745-387-5_3
Rating Scales for Anxiety Disorders
L. Marques (2009)
10.4088/JCP.08m04485blu
Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
N. Simon (2009)
See more
Semantic Scholar Logo Some data provided by SemanticScholar